Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan
Wenyu Ye1, Haya Ascher-Svanum2, Yuka Tanji3, Jennifer A Flynn3, Michihiro Takahashi3,41Lilly Suzhou Pharmaceutical Co, Shanghai, People’s Republic of China; 2Eli Lilly and Company, Indianapolis, IN, USA; 3Lilly Research Laboratories Japan, Eli Lilly Japan KK, Kobe, 4Terauchi-Takahashi...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-12-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/predictors-of-continuation-with-olanzapine-during-the-1-year-naturalis-a8874 |